Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 356 of 6351
-
Can AI help nurses guide At-Risk seniors to better care and lower costs?
Disease control By invitation onlyASCEND-MA is an embedded, health-services study of at-risk Medicare Advantage members attributed to Intermountain Health in Utah. Participants are quasi-randomized based on their medical-record-number parity to either AI-supported, nurse-reviewed proactive care navigation or usua…
Sponsor: Intermountain Health Care, Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New heart catheter aims to tame Life-Threatening rhythm disorder
Disease control Recruiting nowSphere VT is a prospective, multi-center, single-arm, unblinded pivotal clinical study. Adult subjects with recurrent, sustained, monomorphic ventricular tachycardia (MMVT) due to prior myocardial infarction (MI) will be enrolled and treated with the Sphere-9 Catheter and Affera …
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Bringing mental health care to the doorstep: a new approach for HIV patients
Knowledge-focused OngoingMental health conditions, such as depression, anxiety, and harmful alcohol use are prevalent among people with chronic diseases, including HIV, and contribute to poor engagement in care. There is a need to address untreated mental health problems. Community health workers (CHWs) …
Sponsor: University of Maryland, College Park • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Could a vitamin B3 boost erase wrinkles? trial tests topical NAD+ booster
Symptom relief Recruiting nowNiacinamide riboside (topical NR, also known as nicotinamide riboside) is an endogenous compound and a precursor (building block) to the essential cellular co-enzyme, nicotinamide adenine dinucleotide (NAD+). Research published by Maussudi et al. 2012 demonstrated that skin NAD+ …
Sponsor: ChromaDex, Inc. • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Could a common Anti-Nausea drug help kids sleep better after surgery?
Symptom relief Not yet recruitingNausea and vomiting are common complications after anaesthesia, and anaesthetists routinely give medications to prevent them. Dexamethasone and ondansetron are the two most commonly used agents and have a long safety record. However, their effects on sleep, behaviour, and overall…
Phase 4 • Sponsor: Telethon Kids Institute • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Can a Bone-Building drug protect patients with breast cancer spread to bones?
Disease control Recruiting nowThe researchers are doing this study to see if romosozumab is effective at helping with bone formation in people with metastatic breast cancer (MBC) that has spread to the bones. All participants will have osteoporosis. The researchers will also look at bone breakdown (resorption…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can an AI avatar ease the burden of Alzheimer's caregiving?
Symptom relief Not yet recruitingThis pilot randomized controlled trial evaluates the feasibility and preliminary efficacy of VICA, an AI-powered virtual care assistant that delivers evidence-based education, symptom monitoring, and coaching to informal caregivers of people living with Alzheimer's disease and re…
Sponsor: Indiana University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Can a simple habit tracker help prevent SIDS?
Prevention Not yet recruitingSafe sleep recommendations from the American Academy of Pediatrics (AAP) are designed to reduce the risk of sudden infant death syndrome (SIDS) and other sleep-related infant deaths. These recommendations include placing infants on their backs to sleep, using a crib or bassinet, …
Sponsor: State University of New York at Buffalo • Aim: Prevention
Last updated Aug 23, 2026 00:00 UTC
-
Can a common arthritis drug stop Parkinson's before it starts?
Prevention Recruiting nowThis is a phase 2 study to assess the ability of adalimumab as compared to placebo to reduce or prevent progression of synuclein-related neurodegeneration in persons with idiopathic REM Sleep Behavior Disorder (RBD). The Primary Endpoint will be change from baseline in expression…
Phase 2 • Sponsor: Yale University • Aim: Prevention
Last updated Aug 26, 2026 00:00 UTC
-
AI stethoscope aims to cut unnecessary antibiotics in kids with cough
Diagnosis Not yet recruitingPneumonia is the leading infectious cause of death in children under five years of age worldwide, and most of these deaths occur in low- and middle-income countries. In these settings, frontline health workers diagnose pneumonia using the World Health Organization's Integrated Ma…
Phase 4 • Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
Smart ring tracks sleep and heart rate to guide weight-loss care — a trial puts it to the test
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a smart ring that tracks health signals can help adults lose weight and improve their health during obesity treatment. The study includes adults who are having weight-loss surgery or starting weight-loss medication. The Oura Ring tr…
Sponsor: Jeff Reeves • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
A smarter emergency test for heart failure?
Diagnosis Not yet recruitingThe goal of this prospective observational cohort study is to establish a comprehensive clinical prediction rule integrating clinical characteristics, point-of-care testing (POCT) of NT-proBNP, an 8-point LUS, and a rapid cardiac assessment using bedside echocardiography for diag…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
Can a Brain-Targeting drug silence the relentless itch of dialysis?
Symptom relief Not yet recruitingThis study evaluates the efficacy and safety of nalfurafine as a treatment for chronic kidney disease-associated pruritus (CKD-aP) in patients undergoing maintenance hemodialysis twice weekly. Pruritus (severe itching) is a common and distressing symptom in patients with end-sta…
Phase 4 • Sponsor: Indonesia University • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Could playtime sharpen young minds? a trial puts Sports-Based cognitive training to the test
Symptom relief Recruiting nowThis randomized controlled trial will evaluate the effect of a sports-based structured cognitive therapy program on attention, memory, and behavior in school-going children aged 8-12 years with mild to moderate attention or behavioral difficulties. A total of 52 participants will…
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Can a hybrid 3D-Printed splint ease jaw pain better than traditional ones?
Symptom relief Not yet recruitingOcclusal splint therapy is a well-established conservative approach for the management of temporomandibular disorders (TMDs); however, variability in clinical outcomes suggests that no single splint design is universally optimal. Conventional chairside stabilization splints are w…
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
A mobile x-ray van with AI could spot TB before it spreads
Diagnosis Not yet recruitingSPOT-TB (Screening with Portable X-rays for rapid recOgniTion of TB) is a prospective study evaluating a community-based tuberculosis (TB) screening strategy for migrant populations in New York City. The screening intervention integrates mobile ultra-portable digital chest radiog…
Sponsor: Columbia University • Aim: Diagnosis
Last updated Aug 01, 2026 00:00 UTC
-
New cocktail aims to make inoperable liver metastases removable
Disease control Not yet recruitingThis is a single-arm clinical study aiming to enroll 30 colon cancer patients with liver-only metastases. All eligible participants will undergo screening and enrollment after signing the informed consent form. All patients will receive stereotactic body radiation therapy (SBRT)…
Phase 2 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Teamwork in care: could shared Self-Care lessons ease the toll of breast cancer treatment?
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the effect of dyadic self-care education provided to breast cancer patient-caregiver dyads receiving outpatient chemotherapy on patient self-care behaviors, anxiety levels, and caregiver anxiety levels and caregiver burden. Partic…
Sponsor: Ulviye Aydan NACAK • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
A drop of blood, a faster answer: new test aims to outpace sepsis in preterm infants
Diagnosis Not yet recruitingThis pilot study will evaluate whether a rapid point-of-care blood test can help identify early signs of infection and sepsis in preterm infants. The study will include preterm infants born before 37 weeks of pregnancy who are admitted to the neonatal care unit and have a suspect…
Sponsor: Medical University of Graz • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
Could a surgical anesthetic calm unbearable Liver-Related itching?
Symptom relief Not yet recruitingTo explore the effect of esketamine on cholestatic pruritus in patients undergoing hepatobiliary surgery
Sponsor: Tianjin Medical University General Hospital • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC